Similar to what was observed at 21 days, NLRP3 inhibition did not show changes in T-cell influx in the primary tumor (Supplementary Fig. S5C); however, increased PD-1 expression was observed (Supplementary Fig. S5C). This evidence concerns the gene NLRP3 and neoplasm.